Esophageal cancer
Conditions
Interventions
Sponsors
Mianyang Central Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients with esophageal cancer confirmed by histology or cytology; 2. Patients with less than five metastatic lesions; 3. All metastatic lesions can be treated with stereotactic radiotherapy, and the size of lesions can be measured by RECIST version 1.1; 4. Subjects with ECoG score of 0-2; 5. Subjects aged <= 80 years; 6. Patients whose liver function, kidney function and blood routine meet the treatment standard; 7. The patients who signed the formal informed consent for treatment voluntarily participated in this experiment.
Exclusion criteria
Exclusion criteria: 1. Patients who have received immunotherapy in the past; 2. Patients with other malignant tumors; 3. Patients with severe autoimmune diseases such as immune myocarditis and immune pneumonia; 4. Patients who can not understand the trial requirements, or may not comply with the trial requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall survival; | — |
Countries
China
Contacts
Public ContactLidan Geng
Mianyang Central Hospital
Outcome results
None listed